Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F88KP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,362
Award facts
- Contract value 100% obligated
- $14,362.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $14,362.22 to AmerisourceBergen Drug Corp for the supply of DUPIXENT (dupilumab) 300 mg/2 mL pens on January 6, 2026, with a completion date of January 7, 2026. This is a firm fixed-price contract with no set-aside designation, awarded on a competitive basis. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. DUPIXENT is a biologic medication used to treat various inflammatory conditions including atopic dermatitis, asthma, and chronic rhinosinusitis, and its procurement reflects the Defense Logistics Agency Medical Supply Chain's critical need for specialty pharmaceutical products to support military and veteran healthcare systems.
This delivery order operates under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 31, 2031. This comprehensive IDC serves as the primary vehicle for supplying pharmaceutical products and medical supplies globally to military treatment facilities and federal healthcare systems. AmerisourceBergen, as a major pharmaceutical distributor and critical federal vendor, regularly fulfills such specialty medication orders through this framework, demonstrating its substantial capability to meet complex medical procurement requirements across multiple therapeutic domains for the Department of Defense healthcare enterprise.
Quick answers
Who was awarded contract SPE2DR26F88KP?
SPE2DR26F88KP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26F88KP worth?
The government has obligated $14,362 on SPE2DR26F88KP.
Is contract SPE2DR26F88KP an order under another contract?
Yes. SPE2DR26F88KP is a delivery order under SPE2DR25D3010, an indefinite delivery contract.
Was contract SPE2DR26F88KP competed?
The extent of competition for SPE2DR26F88KP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award